Independent report · India Fintech / Payments Infrastructure

Razorpay Pre-IPO Shares: Is the Valuation Reset Enough?

June 28, 2026 · By Reena

Razorpay company material

Independent report content

SECONDARYDEALNOTE · # 0 0 6

Razorpay Pre-IPO Secondary India Fintech · Full-Stack Payments & Financial Services · Pre-IPO Secondary Confidential DRHP filed Jun 12, 2026 IPO target ₹50,000–60,000 Cr June 28, 2026

BUSINESS QUALITY GREEN VALUATION RESET RED IPO PROXIMITY AMBER

SELLER SIGNAL AMBER LIQUIDITY RISK RED

SECON DA RY TY P E Pre-IPO secondary — existing shareholders selling stakes in the unlisted

market ahead of the confidential DRHP filing (Jun 12, 2026). No new shares

issued; no primary capital to the company. SELLERZ47 (formerly Matrix Partners India) — part of a $150–180M multi-company secondary. Other sellers: ESOP holders, early angels, secondary-market participants via unlisted share platforms.

BUYERPROFILE Institutional secondary funds, family offices, UHNI investors via pre-IPO platforms (Forge, NPM, domestic unlisted dealers). Accredited investors only. SECON DA RY PRICE ( EST. ) Unlisted shares ₹85/share (Jun 23, 2026, Planify / Delistedstocks). IPO target

valuation ₹50,000–60,000 Cr ($5–6B). Last private round: $7.5B (Series F, Dec

2021). VA LUAT IONHAIRCUT $7.5B (Series F peak) → $5–6B (IPO target) = 33–37% discount to last private round. A confirmed down-round at IPO. IPOS TAT U S Confidential DRHP filed with SEBI Jun 12, 2026. Size ₹5,000–5,700 Cr (~$600M). Fresh issue ₹2,700 Cr; OFS the balance (Tiger Global, Peak XV, others selling). Listing target: late 2026.

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

FINANCIALS ( FY 2 5 ) Revenue ₹3,783 Cr (+65% YoY) | Gross profit ₹1,277 Cr

(+41%) | POS/prepaid card revenue ₹442 Cr (21x from ₹21 Cr FY24) | Cash ₹2,774 Cr | FY24 PAT ₹33.5 Cr (first profitable year). SCALE $180B annualised TPV | 8M+ merchant businesses | UPI 50.49% of volume, cards 35.67% | RBI PA-CB licence (Jan 2026): 130+ currencies, 180+ countries.

37 THERUPEIANUMBER

The percentage discount from Razorpay's $7.5B Series F peak (Dec 2021) to its IPO target of $5– 6B. Every secondary buyer in the pre-IPO market today is pricing at or below this haircut. The question is whether the IPO price is the floor or the ceiling for secondary entry.

THEG AT INGQUESTION

Razorpay's last private valuation was $7.5B (Series F, December 2021). Its DRHP targets ₹50,000–60,000 Cr ($5–6B) — a 33–37% valuation cut at IPO, the largest confirmed down-round among India's top-tier fintech unicorns. Every secondary buyer who purchases at or above the IPO valuation is betting that public-market pricing will re-rate Razorpay above $5–6B post-listing. At ₹3,783 Cr FY25 revenue, $5B = 9.6x EV/Revenue; $7.5B = 14.3x. The question is which multiple the Indian public market will apply to a profitable payments- infrastructure company growing revenue 65%.

RUPEIA INVESTMENT INTELLIGENCE | JUNE 28, 2026 | SECONDARY DEAL NOTE #006 | PREPARED INDEPENDENTLY

0A CLAIM REGISTER — EVIDENCE GRADING

A = Statutory/regulatory | B = MCA-adjacent / company disclosure | C = Independent press / database | D = Company statement | E = No evidence or conflict

CLAIM SOURCE GRADE RUPEIA ASSESSMENT

FY25 Revenue ₹3,783 Cr (+65% YoY) INDmoney / Bajaj Broking citing DRHP-adjacent + company

disclosures

B HIGH CONFIDENCE. Multiple independent sources, consistent figure. Breakdown (payments ₹3,341 Cr; hardware ₹442 Cr) corroborates. DRHP confidentially filed Jun 12, 2026 Reuters (Jun 15); Bajaj Broking; INDmoney A VERIFIED. Company-initiated confidential DRHP confirmed by multiple tier-1 press.

IPO target valuation ₹50,000–60,000 Cr Press citing SEBI filing intelligence; Bajaj Broking Jun C PROBABLE. Sources consistent. Confidential DRHP = figures not publicly filed yet. Treat as a working range.

Last private valuation $7.5B (Series F, Dec 2021) CoinLaw.io; investor databases;

company statements

A VERIFIED. $490M Series F co-led by Lone Pine, Alkeon, TCV at $7.5B post-money — widely corroborated.

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

CLAIM SOURCE GRADE RUPEIA ASSESSMENT

$180B annualised TPV Company-stated; CoinLaw.io Jun C PROBABLE. Company figure; independent verification not possible. Directionally credible given merchant scale. Z47 secondary sale ($150–180M multi-

company)

ET (Oct 2024); Inc42;

MarketScreener

C PROBABLE. Sources consistent. Transaction not publicly confirmed closed; may have evolved since Oct 2024. FY24 PAT ₹33.5 Cr (first profitable year)

Inc42 IPO Tracker 2026; multiple

sources

B HIGH CONFIDENCE. Consistent across sources. Net loss in FY24 was driven by a ₹1,209 Cr ESOP expense; underlying PAT is ₹33.5 Cr as reported. Unlisted share price ₹85/share (Jun 23, 2026)

Planify.in / Delistedstocks.in C SIGNAL — not a verified transaction price. Unlisted prices are indicative. Use as directional signal only. Reverse flip complete (India parent entity)

Inc42 IPO Tracker; press (May 2025) A VERIFIED. Restructuring confirmed by press and company. Prerequisite for India IPO completed.

1 COMPANY OVERVIEW — WHAT RAZORPAY ACTUALLY IS

Razorpay is not a payment gateway. It is India's financial operating system for businesses. A payment gateway was the founding product in 2014; by 2026 it is the layer that processes payments, manages payroll, disburses vendor payments, provides working-capital loans, handles international collections across 130+ currencies, and now executes agentic AI payment flows embedded in Claude and OpenAI APIs.

ENTI TY Razorpay Software Limited (converted from Private to Public Ltd as a pre-IPO step). ROC: Bengaluru. CIN and ISIN available. FOUNDED 2014 by Harshil Mathur (CEO) and Shashank Kumar (CTO). IIT Roorkee alumni. YC 2015 batch. India-born, India-focused from founding.

REVERSEFLIP May 2025: US holding entity (Razorpay Inc.) merged into the Indian entity — prerequisite for a domestic IPO. The ₹1,209 Cr FY24 ESOP expense from this restructuring is the financial overhang. PRODU CT SUITE Payments: gateway, links, pages, QR, smart collect. RazorpayX: current accounts, payouts, payroll, line of credit. Razorpay Capital: business loans. Hardware: POS machines + prepaid cards. Magic Checkout (conversion). International: 130+ currencies, 180+ countries (RBI PA-CB licence Jan 2026).

SCALE ( FY 2 5 ) $180B annualised TPV | 8M+ merchants | UPI 50.49% of volume (3.7B monthly txns) | cards 35.67% | POS/hardware revenue ₹442 Cr (21x YoY) | payroll 40,000+

businesses.

TOTA LRAISED $822M+. Investors: Y Combinator, Tiger Global, Peak XV Partners, Lone Pine, Alkeon, GIC, TCV, Lightspeed. 19 investors (PitchBook). 4,035 employees.

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

COMPETITION Paytm (payment-services revenue declined post-RBI action), PhonePe (UPI- dominant, B2B less developed), Pine Labs (offline POS + credit), PayU (B2B, Prosus-owned). Razorpay is strongest in B2B developer-first payments; PhonePe stronger in consumer UPI.

2 THE SECONDARY DEAL — WHO IS SELLING AND WHY

SECONDARYDEALAN AT OMY

A pre-IPO secondary is not a primary fundraise. No money goes to Razorpay; the company receives no capital. Existing shareholders sell to new buyers at a negotiated price. The buyer is buying the right to participate in the IPO at the secondary price — hoping the IPO or post-listing price exceeds what they paid. The seller is de-risking: converting paper wealth to cash before the IPO lock-in period begins.

Why Z47 is selling Why buyers are entering DPI pressure (Rupeia interpretation): Z47 is raising its first independent fund ($300–400M) after separating from Matrix Partners US in June 2024. LPs evaluating a new fund want to see DPI — actual cash returned, not paper marks. Selling Razorpay, OfBusiness, Ola and Dailyhunt stakes converts marks into cash before the new fund closes.

–

Fund lifecycle: Matrix Partners India Funds I–III are aging; these investments were made 8–12 years ago.

AIF regulations and LP agreements typically require disposal within fund life. Secondaries are the mechanism. – Concentration management: Z47 holds large positions in Razorpay, OfBusiness and Ola Electric — a significant share of total AUM. Partial de-risking is prudent.

– IPO timing arbitrage: Secondary buyers lock in before IPO. Z47 sells now for certainty rather than waiting for IPO lock-up expiry (6 months for VC/AIF per SEBI rules). – Forced-discount access: Public-market investors cannot access Razorpay at $5B. Secondary buyers get in at an implied discount to the IPO price — typically 10–20% below anticipated listing price. At ₹85/share, buyers are effectively pricing Razorpay below the IPO target range.

+ Infrastructure-premium thesis: Razorpay is India's payment infrastructure, not replaceable by PhonePe or Paytm in B2B. 8M merchants do not switch processors without major disruption. Infrastructure trades at revenue premiums globally (Stripe ~12x, Adyen 20x+ at peak); India's public market has never priced a pure-play B2B payment-infrastructure company.

+

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

3 FINANCIAL ANALYSIS — WHAT THE BUSINESS IS WORTH

METRIC FY24 FY25 GROWTH RUPEIA COMMENT

Operating

Revenue ₹2,283– 2,475 Cr ₹3,783 Cr +65% Strong. Hardware jump (POS ₹442 Cr from ₹21 Cr) = structural shift.

Core payments grew too. Gross Profit ₹904 Cr ₹1,277 Cr +41% Gross margin compressing: 39.3% → 33.8%. Hardware at lower margin than software payments. PAT (reported) ₹33.5 Cr Not yet filed — FY24 first profitable year, but ₹1,209 Cr ESOP expense distorts. Core economics profitable. FY25 PAT not yet public.

Cash & equivalents — ₹2,774 Cr — Strong pre-IPO liquidity. Healthy buffer. TPV (annualised) $150B (Feb 2024)

$180B +20% Volume growth slower than revenue growth — mix shift to higher- margin products. Revenue / TPV take rate ~0.17% ~0.21% Improving Take-rate expansion = pricing power + product-mix shift. Positive signal.

Valuation arithmetic — three scenarios

SCENARIO EV/REVENUE

IMPLIED

VALUATION BASIS

SECONDARY ENTRY

ATTRACTIVENESS

BEAR — IPO

underprices 6x FY25 rev $2.7B (~₹22,500 Cr) Paytm post-correction (0.5x), Pine Labs (4x). Market prices India payments at deep discount.

AVOID secondary above $2.5B. Wait for post- IPO correction.

BASE — IPO

target 9–10x FY25 rev $5–6B (~₹42,000– 50,000 Cr) DRHP target. Comparable to Adyen at scale. Reasonable for a profitable Indian fintech infra.

Secondary at 10–15% below IPO target (₹42,500–45,000 Cr) = FAIR VALUE for a long- term holder. BULL — public re-rate 14–16x FY25 rev $7.5–9B Stripe comp (private, 12x). India premium for network effects + lending + payroll ecosystem.

Secondary at $5B = 50% upside if bull case. Requires 3–5 year hold through IPO + re-rate.

THEDOWN - ROUNDCONTEXT

Razorpay's last private round was $7.5B (Series F, Dec 2021); the IPO targets $5–6B. This is a 33–37% writedown of the 2021 peak — caused by global fintech multiple compression (Paytm listed at $20B, now ~$3–4B), Indian public-market distrust of loss-making fintechs, and Razorpay's own ESOP expense distorting FY24 profitability. The silver lining: $5B for a business doing $180B TPV and growing 65% is reasonable IF the trajectory holds. The risk: India's payment market is moving to zero-MDR UPI, which compresses take rates structurally. Razorpay's answer — POS, payroll, lending, international — is the right strategic response; the execution question is whether these adjacencies grow fast enough.

Lock-in risk (the cost of entry): SEBI mandates VC/AIF pre-IPO buyers locked 6 months from acquisition; retail/HNI buyers locked 6 months from listing. A buyer at ₹85/share today who holds through a late-2026 IPO may be locked until mid-2027. +

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

4 KEY RISKS — WHAT A SECONDARY BUYER IS PRICING

RISK DETAIL MITIGANT RESIDUAL

UPI zero-MDR take-rate compression UPI = 50.49% of volume at zero merchant discount rate. As UPI grows, take rate declines unless offset by premium products.

Mix shift to POS (₹442 Cr), payroll, lending — all higher margin. International (PA-CB) adds premium revenue.

MEDIUM — mix shift working but ongoing. Volume growth must outpace take-rate decline.

IPO down-round perception Listing at $5–6B vs $7.5B last round. Retail will see "below last round" in every article. Sentiment risk.

65% revenue growth + profitability + ₹2,774 Cr cash justify the price. 2026 IPO market is sophisticated (Meesho, Groww listed well).

MEDIUM — sentiment risk is real; first-day pop not guaranteed. Lock-in (SEBI 6- month rule)

AIF/VC pre-IPO buyers locked 6 months from acquisition; HNI/retail 6 months from listing. Illiquidity window significant.

Treat as a 12–18 month minimum hold (acquisition + lock-in + listing timeline). Size accordingly. HIGH as liquidity risk — structural, not operational.

Competition — PhonePe merchant services PhonePe expanding into B2B with 500M+ consumer base. CRED, Amazon Pay also entering merchant payments.

Razorpay's developer-first API infrastructure is far more mature. Switching costs for 8M integrated merchants are high.

MEDIUM-LOW — switching- cost moat real but PhonePe has distribution. ESOP overhang at IPO ₹1,209 Cr FY24 ESOP expense from reverse-flip structuring. Employee ESOP vesting may create post-IPO selling pressure.

SEBI lock-in applies to pre-IPO ESOP holders too (6 months post-listing). Selling pressure concentrated in H1 2027.

MEDIUM — known risk; factor into price. Revenue concentration (India payments)

India B2B payments = majority of revenue. International is nascent (₹18 Cr FY25, <1%). RBI PA-CB licence (Jan 2026) enables international. Malaysia (Curlec)

operational. Multi-year growth vector. MEDIUM — international real but early-stage.

5 INVESTOR COMFORT CHECKS — ASK BEFORE BUYING

CHECK WHAT TO VERIFY

Entry price logic What is your effective entry EV/Revenue multiple? At ₹85/share, implied market cap depends on diluted share count — verify total diluted shares from RoC (Form PAS-3) to calculate precise valuation. Do not accept the unlisted price at face value. Lock-in calendar Calculate your exact 6-month lock-in from acquisition date. Buy unlisted Jun 2026 + IPO Nov 2026 → lock-in ends ~May 2027. Can you hold? Is your fund/family-office liquidity matched to this timeline?

Seller motivation Confirm Z47's specific stake size and what exactly is for sale (all or partial; structured block vs open market).

Structured block sales give ROFR and block pricing — better than open market.

OFS size at IPO Which investors are in the OFS? Tiger Global + Peak XV are the largest holders. Large blocks sold at IPO signal lower conviction; retention is a positive signal. FY26 revenue run rate Razorpay has cited "adjusted revenue" of ₹9,891 Cr in Q2 FY26 (756% growth — appears to include platform GMV, not own revenue). Clarify exactly what this figure represents before using it in valuation.

RBI regulatory

risk

Razorpay holds RBI PA + new PA-CB licences. Any RBI action (à la Paytm Payments Bank 2024) would be existential. Ask: any RBI compliance notices? PA licence renewal status? Profitability trajectory FY24 PAT ₹33.5 Cr is thin. Ask FY25 PAT (not yet public), whether ESOP is normalized, and whether the business generates FCF before working-capital interest.

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

6 SECONDARY DEAL VERDICT

THERUPEIAANSWER

Is Razorpay a good secondary buy? CONDITIONALLY YES — at the right price. At ₹3,783 Cr FY25 revenue growing 65%, $5B (9.6x EV/Revenue) is defensible for a profitable fintech-infrastructure

company. Secondary entry at 10–15% below the IPO target (₹42,000–45,000 Cr equivalent) gives a

buffer. The 6-month lock-in is a cost of entry that must be priced. The risks are UPI take-rate compression (structural), IPO sentiment around the down-round narrative, and the ESOP overhang. The opportunity is the first-ever Indian public-market pricing of a profitable B2B payment- infrastructure company at what may be a historically low multiple versus global comps (Adyen, Stripe).

Long-term investors with a 3–5 year horizon: the base case is compelling. Short-term traders hoping for an IPO-day pop: Z47 is selling to you — think about which side of that trade you want to be on.

7 SOURCE LOG

REF SOURCE DATE KEY DATA

[1] CoinLaw.io — Razorpay Statistics Jun 2026 FY25 revenue ₹3,783 Cr, gross profit ₹1,277 Cr, $180B TPV, DRHP Jun 12, Q2 FY26 ₹9,891 Cr adjusted revenue. [2] INDmoney — Razorpay IPO overview Jun 2026 Revenue ₹3,783 Cr FY25 (+65%), cash ₹2,774 Cr, fresh issue ₹2,700 Cr, total ₹5,700 Cr IPO.

[3] Bajaj Broking — Razorpay IPO Jun 12–15, Confidential DRHP confirmed. IPO target ₹50,000–60,000 Cr. Fresh issue ₹2,700 Cr approved. [4] Inc42 — Indian Startup IPO Tracker 2026 Jun 2026 Founded 2014; IIT Roorkee; FY24 PAT ₹33.5 Cr; ESOP expense ₹1,209 Cr; reverse flip May 2025.

[5] Inshorts via Moneycontrol — Z47 secondary Jun 2026 Z47 plans $200M secondary in OfBusiness; holds 10.8% stake; multi-company programme.

[6] Inc42 — Z47 multi-company secondary Oct 2024 Z47 exploring $150–180M stake sales in Ola, OfBusiness, Razorpay, Dailyhunt.

[7] Planify.in / Delistedstocks.in Jun 23, 2026 Unlisted shares ₹85/share. ISIN available. Indicative price only. [8] VFS — Razorpay valuation report May 2026 $9.2B reflects an implied/secondary-market valuation — not a confirmed primary round. Directional only. The Standard This is a secondary deal note prepared without access to the company data room or the confidential DRHP. Every figure is independently sourced; where a figure is indicative (unlisted price) or unconfirmed (IPO valuation range), it is labelled as such. Razorpay is a profitable B2B payment- infrastructure business at a confirmed IPO down-round. The secondary is conditionally attractive for a long-term holder who enters below the IPO target and can carry the 6-month lock-in. Verify diluted share count, FY25 PAT, and the Q2 FY26 "adjusted revenue" definition before committing.

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006

DISCLAIMER

This document is published strictly for informational, educational, and academic record-keeping purposes only. The publisher of this document is not a SEBI Registered Investment Adviser (RIA), nor a SEBI Registered Research Analyst (RA). This report does not constitute personal investment advice, an independent research report, a financial recommendation, or an offer or solicitation to buy, sell, or subscribe to any securities. Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.

RUPEIA | SECONDARYDEALNOTE # 0 0 6 | RAZOR PAY PRE - IPOSECONDARY | JUNE 2 8 , 2 0 2 6

RUPEIA RAZORPAY PRE-IPO SECONDARY SECONDARY DEAL NOTE #006